MEDP · Nasdaq · CIK 0001668397
Medpace Holdings, Inc.
Medpace Holdings, Inc.’s most recent SEC filing in our snapshot is a Form 144 filed on Oct 27, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $2.5B and net income of $451.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 74 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Medpace Holdings, Inc.
- Ticker
- MEDP
- SEC Central Index Key (CIK)
- 0001668397
- Industry (SIC)
- Services-Commercial Physical & Biological Research (code 8731)
- Business address
- CINCINNATI, OH
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #615 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Medpace Holdings, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $1.9B | $2.1B | $2.5B |
| Net income | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M |
| Diluted EPS | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |
| Total assets | $1.7B | $1.4B | $1.7B | $2.1B | $2.0B |
| Cash and equivalents | $461.3M | $28.3M | $245.4M | $669.4M | $497.0M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 10, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Oct 22, 2026 | 10-Q | Quarterly report· period Sep 30, 2026 | Document · Index |
| Oct 21, 2026 | 8-K | Results of operations; Other events· period Oct 20, 2026 | Document · Index |
| Apr 1, 2026 | DEF 14A | Definitive proxy statement· period May 15, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Medpace Holdings, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 27, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Oct 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Oct 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 21, 2026 | Document · Index |
| Oct 22, 2026 | 10-Q | Quarterly report· period Sep 30, 2026 | Document · Index |
| Oct 21, 2026 | 8-K | Results of operations; Other events· period Oct 20, 2026 | Document · Index |
| Oct 14, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 12, 2026 | Document · Index |
| Oct 9, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 7, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 29, 2026 | Document · Index |
| Sep 29, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 25, 2026 | Document · Index |
| Sep 28, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Sep 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 23, 2026 | Document · Index |
| Sep 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 21, 2026 | Document · Index |
| Sep 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 17, 2026 | Document · Index |
| Sep 17, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026 | Document · Index |
| Sep 17, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026 | Document · Index |
| Aug 31, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 27, 2026 | Document · Index |
| Aug 28, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 26, 2026 | Document · Index |
| Aug 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 25, 2026 | Document · Index |
| Aug 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 21, 2026 | Document · Index |
| Aug 24, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 20, 2026 | Document · Index |
| Aug 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026 | Document · Index |
| Aug 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026 | Document · Index |
| Aug 21, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 19, 2026 | Document · Index |
| Aug 20, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 19, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 19, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 14, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 12, 2026 | Document · Index |
| Aug 14, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 13, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026 | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026 | Document · Index |
| Aug 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026 | Document · Index |
| Aug 7, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 29, 2026 | 144/A | 144/A | Document · Index |
| Jul 29, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 28, 2026 | Document · Index |
| Jul 29, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026 | Document · Index |
Insider filing activity
74 Form 4 filings appear in Medpace Holdings, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Services-Commercial Physical & Biological Research
- IQV IQVIA HOLDINGS INC.
- INCY INCYTE CORP
- CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- ICLR ICON PLC
- ABSI Absci Corp
- OABI OmniAb, Inc.
- NRC NRC HEALTH
All 8 companies in Services-Commercial Physical & Biological Research· Companies headquartered in Ohio
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001668397 and XBRL company facts. Medpace Holdings, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement